This once-weekly prefilled injector, designed for both type 2 diabetes and obesity, expands the drug's availability from the initial 2.5mg and 5mg vials to include six strengths (2.5, 5, 7.5, 10, 12.5, and 15mg)
Those observations describe monitored trial participants under a defined study design
Reports indicate that regulatory submission is expected to follow completion of these trials
Don't wait for a patient portal response for any of these
It is a promising investigational amylin analog, not an approved therapy, and its gastric-emptying credentials are best described as mechanistically well-founded but not yet fully quantified in humans over time
works well as a bridge snack between minimal meals Small bowl of miso soup with silken tofu ~8g protein, ~80 kcal